Form 4: Arteris COO Sells Shares to Cover Tax Liability
Statement of Changes in Beneficial Ownership
Arteris, Inc. Chief Operating Officer Moll Laurent R has reported the sale of company shares to cover tax obligations and transactions made under a pre-arranged trading plan.
Summary
- Moll Laurent R, Chief Operating Officer of Arteris, Inc., reported transactions involving the sale of common stock on April 2, 2026, and April 6, 2026.
- On April 2, 2026, a total of 888 + 1,931 + 1,890 + 893 = 5,602 shares were sold at a price of $17.6528 per share.
- These sales on April 2, 2026, were made to satisfy the Reporting Person's tax liability arising from the release of restricted stock units, as mandated by the Issuer's equity incentive plans for tax withholding.
- On April 6, 2026, an additional 1,552 shares were sold at a price of $18.23 per share.
- This transaction on April 6, 2026, was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions related to tax obligations and pre-planned sales, rather than indicating significant changes in the executive's confidence in the company's future.
Negatives
- The reporting person sold a total of 7,154 shares of Arteris, Inc. common stock.
- The sales on April 2, 2026, were to cover tax liabilities, indicating a cash outflow for the reporting person related to equity compensation.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing.
Management Comments
- Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2025.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a 10b5-1 plan by Arteris, Inc.'s COO is a common strategy for executives to sell shares in a pre-determined manner, mitigating concerns about insider trading, especially when sales are tied to tax obligations.
Stakeholder Impact
- Shareholders: The sales, particularly those under the 10b5-1 plan, may be interpreted by the market. However, the explicit explanation that sales are to cover tax liabilities and are part of a pre-arranged plan aims to reduce negative perceptions.
- Employees: The reporting person's tax obligations related to equity compensation highlight the nature of executive compensation structures.
- Management: The filing confirms adherence to reporting requirements and the use of compliance-oriented trading plans.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 04/02/2026 | Date of initial stock sales to cover tax liabilities. |
| 04/06/2026 | Date of stock sale made pursuant to the 10b5-1 trading plan. |
| 04/06/2026 | Signature Date of the filing. |
Keywords
Arteris Inc, Form 4, Moll Laurent R, insider trading, stock sale, tax liability, 10b5-1 plan, restricted stock units, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.